Skip to Main Content
Our Commitment to Diversity

Qui Tam Quarterly

Hunting Telehealth Fraud Under COVID-19 Waivers and Expansion

Date: 27 August 2021

Over the COVID-19 pandemic, telehealth has evolved from an infrequent method of providing health care services that was often abused into a vital tool used by providers to connect with patients. This article examines fraudulent uses of telehealth, government agency uses of claims analysis and data analytics in telehealth fraud investigations, and government agency technological advancements in this regard. This article also provides recommendations on how to minimize risk of involvement in improper telehealth arrangements.

Key Takeaways
  1. COVID-19 Telehealth Expansion Created Opportunities for Fraud
  2. The Data Analytics and Technology Used in Telehealth Fraud Investigations Impact Compliance Measures
  3. Best Practices to Minimize Telehealth Enforcement Risk
Download the Newsletter

ABOUT QUI TAM QUARTERLY

Qui Tam Quarterly is a quarterly publication authored by members of the health care fraud and abuse team highlighting emerging and pressing issues in health care fraud and abuse, including litigation and governmental investigations involving the False Claims Act, the Stark Law, the Anti-Kickback Statute, and other health care fraud related statutes.

Members of our team are regular contributors to Triage: Timely Conversations for Health Care Professionals, a podcast created by K&L Gates to inform our clients and friends of the firm about the latest developments in health law.

Subscribe to Triage through Apple Podcasts, Google Podcasts, and Spotify to have our episodes delivered directly to you as they become available.

Return to top of page

Email Disclaimer

We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.

Accept Cancel